SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Grand View Research | PRODUCT CODE: 2132537

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2132537

Europe Medical Foods Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Enteral), By Product (Pills, Liquid), By Application, By Modules, By Sales Channel, By Country, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Europe Medical Foods Market Summary

The Europe medical foods market size was valued at USD 6.3 billion in 2025 and is projected to grow from USD 6.5 billion in 2026 to USD 7.9 billion by 2033, growing at a CAGR of 2.8% from 2026 to 2033. The growth is attributed to Europe's large and aging population, which is increasingly susceptible to chronic and age-related conditions, including cardiovascular and respiratory diseases, thereby driving demand for specialized nutritional solutions and medical foods to support disease management and improve overall health outcomes.

Europe Medical Foods Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Europe medical foods market report based on route of administration, product, application, modules, sales channel, and region.

  • Route of Administration Outlook (Revenue, USD Billion, 2021 - 2033)
  • Oral
  • Enteral
  • Product Outlook (Revenue, USD Billion, 2021 - 2033)
  • Pills
  • Powder
  • Liquid
  • Others (semisolid, semiliquid)
  • Application Outlook (Revenue, USD Billion, 2021 - 2033)
  • Chronic Kidney Disease
  • Minimal Hepatic Encephalopathy
  • Chemotherapy Induced Diarrhoea
  • Pathogen Related Infections
  • Diabetic Neuropathy
  • ADHD
  • Depression
  • Alzheimer's Disease
  • Nutritional Deficiency
  • Orphan Diseases
    • Tyrosinemia
    • Eosinophilic Esophagitis
    • Food Protein Module-induced enterocolitis syndrome (FPIES)
    • Phenylketonuria (PKU)
    • Maple syrup urine disease (MSUD)
    • Homocystinuria
    • Others (Urea Cycle Disorder (UCD), Glycogen Storage Disease (GSD), etc.)
  • Wound Healing
  • Chronic Diarrhea
  • Constipation Relief
  • Protein Booster
  • Dysphagia
  • Pain Management
  • Parkinson's Disease
  • Epilepsy
  • Other Cancer related treatments
  • Severe Protein Allergy
  • Cancer
  • Cachexia
  • Other (debilitating conditions, COPD, etc.)
  • Modules Outlook (Revenue, USD Billion, 2021 - 2033)
  • Amino Acid Module
  • Protein Module
  • Vitamin & Mineral Modules
  • Fatty Acid based Modules
  • Carbohydrate Modules
  • Fiber Modules
  • Ketogenic Modules
  • Peptide based Modules
  • Hypoallergic Modules
  • Others (Electrolyte Module, etc.)
  • Sales Channel Outlook (Revenue, USD Billion, 2021 - 2033)
  • DTC Sales Channel
    • Online Sales
    • Retail Sales
  • Institutional Sales
    • Hospitals
    • Others (Long-term Care Facilities, etc.)
  • Country Outlook (Revenue, USD Billion, 2021 - 2033)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Denmark
  • Sweden
  • Norway
  • Poland
  • Netherlands
  • Portugal
  • Slovakia
  • Finland
  • Czech Republic
  • Hungary
  • Belgium
Show more
Product Code: GVR-4-68039-943-6

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Route of Administration
    • 1.1.2. Product
    • 1.1.3. Application
    • 1.1.4. Modules
    • 1.1.5. Sales Channel
    • 1.1.6. Country scope
  • 1.2. Estimates and forecast timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database.
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Route of administration outlook
    • 2.2.2. Product outlook
    • 2.2.3. Application outlook
    • 2.2.4. Modules outlook
    • 2.2.5. Sales channel outlook
    • 2.2.6. Country outlook
  • 2.3. Competitive Insights

Chapter 3. Europe Medical Foods Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising incidence of chronic diseases
      • 3.2.1.2. Increasing Geriatric Population and Chronic Disease Burden
      • 3.2.1.3. Rising Nutritional Deficiencies and Malnutrition
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Cost of Specialized Medical Foods
      • 3.2.2.2. Reimbursement and Insurance Limitations
  • 3.3. Regulatory Framework
  • 3.4. Pricing Analysis (Oral & Enteral)
    • 3.4.1. Standardized pricing by form of product, by country (2025)
      • 3.4.1.1. UK
      • 3.4.1.2. Germany
      • 3.4.1.3. Spain
      • 3.4.1.4. France
      • 3.4.1.5. Italy
      • 3.4.1.6. Denmark
      • 3.4.1.7. Sweden
      • 3.4.1.8. Norway
      • 3.4.1.9. Poland
      • 3.4.1.10. Netherlands
      • 3.4.1.11. Portugal
      • 3.4.1.12. Slovakia
      • 3.4.1.13. Finland
      • 3.4.1.14. Czech Republic
      • 3.4.1.15. Hungary
      • 3.4.1.16. Belgium
  • 3.5. Industry Analysis
    • 3.5.1. User Perspective Analysis
    • 3.5.2. Key End Users
  • 3.6. Technology Outlook
    • 3.6.1. Technology Timeline
  • 3.7. Europe Medical Foods Market Analysis Tools
    • 3.7.1. Industry Analysis - Porter's Five Forces
      • 3.7.1.1. Supplier power
      • 3.7.1.2. Buyer power
      • 3.7.1.3. Substitution threat
      • 3.7.1.4. Threat of new entrant
      • 3.7.1.5. Competitive rivalry
    • 3.7.2. PESTEL Analysis
      • 3.7.2.1. Political landscape
      • 3.7.2.2. Economic landscape
      • 3.7.2.3. Social landscape
      • 3.7.2.4. Technological landscape
      • 3.7.2.5. Environmental landscape
      • 3.7.2.6. Legal landscape

Chapter 4. Europe Medical Foods Market: Route of Administration Estimates & Trend Analysis

  • 4.1. Route of Administration Market Share, 2025 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Europe Medical Foods Market by Route of Administration Outlook
  • 4.4. Oral
    • 4.4.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 4.5. Enteral
    • 4.5.1. Market estimates and forecast, 2021 - 2033 (USD Billion)

Chapter 5. Europe Medical Foods Market: Product Estimates & Trend Analysis

  • 5.1. Product Market Share, 2025 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Europe Medical Foods Market by Product Outlook
  • 5.4. Pills
    • 5.4.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 5.5. Powder
    • 5.5.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 5.6. Liquid
    • 5.6.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 5.7. Others (semisolid, semiliquid)
    • 5.7.1. Market estimates and forecast, 2021 - 2033 (USD Billion)

Chapter 6. Europe Medical Foods Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2025 & 2033
  • 6.2. Segment Dashboard
  • 6.3. Europe Medical Foods Market by Application Outlook
  • 6.4. Chronic Kidney Disease
    • 6.4.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.5. Minimal Hepatic Encephalopathy
    • 6.5.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.6. Chemotherapy Induced Diarrhea
    • 6.6.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.7. Pathogen Related Infections
    • 6.7.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.8. Diabetic Neuropathy
    • 6.8.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.9. ADHD
    • 6.9.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.10. Depression
    • 6.10.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.11. Alzheimer's Disease
    • 6.11.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.12. Nutritional Deficiency
    • 6.12.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.13. Orphan Diseases
    • 6.13.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 6.13.2. Tyrosinemia
      • 6.13.2.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 6.13.3. Eosinophilic Esophagitis
      • 6.13.3.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 6.13.4. Food Protein Module-induced enterocolitis syndrome (FPIES)
      • 6.13.4.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 6.13.5. Phenylketonuria (PKU)
      • 6.13.5.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 6.13.6. Maple syrup urine disease (MSUD)
      • 6.13.6.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 6.13.7. Homocystinuria
      • 6.13.7.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 6.13.8. Others (Urea Cycle Disorder (UCD), Glycogen Storage Disease (GSD), etc.)
      • 6.13.8.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.14. Wound Healing
    • 6.14.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.15. Chronic Diarrhea
    • 6.15.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.16. Constipation Relief
    • 6.16.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.17. Protein Booster
    • 6.17.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.18. Dysphagia
    • 6.18.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.19. Pain Management
    • 6.19.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.20. Parkinson's Disease
    • 6.20.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.21. Epilepsy
    • 6.21.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.22. Other Cancer related treatments
    • 6.22.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.23. Severe Protein Allergy
    • 6.23.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.24. Cancer
    • 6.24.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.25. Cachexia
    • 6.25.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 6.26. Other (debilitating conditions, COPD, etc.)
    • 6.26.1. Market estimates and forecast, 2021 - 2033 (USD Billion)

Chapter 7. Europe Medical Foods Market: Modules Estimates & Trend Analysis

  • 7.1. Modules Market Share, 2025 & 2033
  • 7.2. Segment Dashboard
  • 7.3. Europe Medical Foods Market by Modules Outlook
  • 7.4. Amino Acid Module
    • 7.4.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 7.5. Protein Module
    • 7.5.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 7.6. Vitamin & Mineral Modules
    • 7.6.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 7.7. Fatty Acid based Modules
    • 7.7.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 7.8. Carbohydrate Modules
    • 7.8.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 7.9. Fiber Modules
    • 7.9.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 7.10. Ketogenic Modules
    • 7.10.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 7.11. Peptide based Modules
    • 7.11.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 7.12. Hypoallergic Modules
    • 7.12.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 7.13. Others (Electrolyte Module, etc.)
    • 7.13.1. Market estimates and forecast, 2021 - 2033 (USD Billion)

Chapter 8. Europe Medical Foods Market: Sales Channel Estimates & Trend Analysis

  • 8.1. Sales Channel Market Share, 2025 & 2033
  • 8.2. Segment Dashboard
  • 8.3. Europe Medical Foods Market by Sales Channel Outlook
  • 8.4. DTC Sales Channel
    • 8.4.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 8.4.2. Online Sales
      • 8.4.2.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 8.4.3. Retail Sales
      • 8.4.3.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
  • 8.5. Institutional Sales
    • 8.5.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 8.5.2. Hospitals
      • 8.5.2.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 8.5.3. Others (Long-term Care Facilities, etc.)
      • 8.5.3.1. Market estimates and forecast, 2021 - 2033 (USD Billion)

Chapter 9. Europe Medical Foods Market: Country Estimates & Trend Analysis, By Route of Administration, By Product, By Application, By Modules, By Sales Channel

  • 9.1. Country Market Share Analysis, 2025 & 2033
  • 9.2. Country Market Dashboard
  • 9.3. Country Market Snapshot
  • 9.4. Market Size & Forecasts Trend Analysis, 2021 to 2033:
    • 9.4.1. UK
      • 9.4.1.1. Key country dynamics
      • 9.4.1.2. Regulatory framework
      • 9.4.1.3. Competitive scenario
      • 9.4.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 9.4.2. Germany
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework
      • 9.4.2.3. Competitive scenario
      • 9.4.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 9.4.3. Spain
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework
      • 9.4.3.3. Competitive scenario
      • 9.4.3.4. Spain market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 9.4.4. France
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Regulatory framework
      • 9.4.4.3. Competitive scenario
      • 9.4.4.4. France market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 9.4.5. Italy
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Regulatory framework
      • 9.4.5.3. Competitive scenario
      • 9.4.5.4. Italy market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 9.4.6. Denmark
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Regulatory framework
      • 9.4.6.3. Competitive scenario
      • 9.4.6.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 9.4.7. Sweden
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Regulatory framework
      • 9.4.7.3. Competitive scenario
      • 9.4.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 9.4.8. Norway
      • 9.4.8.1. Key country dynamics
      • 9.4.8.2. Regulatory framework
      • 9.4.8.3. Competitive scenario
      • 9.4.8.4. Norway market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 9.4.9. Poland
      • 9.4.9.1. Key country dynamics
      • 9.4.9.2. Regulatory framework
      • 9.4.9.3. Competitive scenario
      • 9.4.9.4. Poland market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 9.4.10. Netherlands
      • 9.4.10.1. Key country dynamics
      • 9.4.10.2. Regulatory framework
      • 9.4.10.3. Competitive scenario
      • 9.4.10.4. Netherlands market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 9.4.11. Portugal
      • 9.4.11.1. Key country dynamics
      • 9.4.11.2. Regulatory framework
      • 9.4.11.3. Competitive scenario
      • 9.4.11.4. Portugal market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 9.4.12. Slovakia
      • 9.4.12.1. Key country dynamics
      • 9.4.12.2. Regulatory framework
      • 9.4.12.3. Competitive scenario
      • 9.4.12.4. Slovakia market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 9.4.13. Finland
      • 9.4.13.1. Key country dynamics
      • 9.4.13.2. Regulatory framework
      • 9.4.13.3. Competitive scenario
      • 9.4.13.4. Finland market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 9.4.14. Czech Republic
      • 9.4.14.1. Key country dynamics
      • 9.4.14.2. Regulatory framework
      • 9.4.14.3. Competitive scenario
      • 9.4.14.4. Czech Republic market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 9.4.15. Hungary
      • 9.4.15.1. Key country dynamics
      • 9.4.15.2. Regulatory framework
      • 9.4.15.3. Competitive scenario
      • 9.4.15.4. Hungary market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 9.4.16. Belgium
      • 9.4.16.1. Key country dynamics
      • 9.4.16.2. Regulatory framework
      • 9.4.16.3. Competitive scenario
      • 9.4.16.4. Belgium market estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Company Market Position Analysis, 2025
  • 10.3. Company Market Share Analysis, 2025
    • 10.3.1. Company Market Share Analysis for Oral Medical Foods, 2025
    • 10.3.2. Company Market Share Analysis for Enteral Medical Foods, 2025
  • 10.4. Strategy Mapping
  • 10.5. Company Profiles/Listing
    • 10.5.1. Danone (Nutricia)
      • 10.5.1.1. Company overview
      • 10.5.1.2. Financial performance
      • 10.5.1.3. Product benchmarking
      • 10.5.1.4. Strategic initiatives
    • 10.5.2. Nestle Health Science
      • 10.5.2.1. Company overview
      • 10.5.2.2. Financial performance
      • 10.5.2.3. Product benchmarking
      • 10.5.2.4. Strategic initiatives
    • 10.5.3. Abbott
      • 10.5.3.1. Company overview
      • 10.5.3.2. Financial performance
      • 10.5.3.3. Product benchmarking
      • 10.5.3.4. Strategic initiatives
    • 10.5.4. Targeted Medical Pharma, Inc. (Physician Therapeutics, LLC, is a division of the company)
      • 10.5.4.1. Company overview
      • 10.5.4.2. Financial performance
      • 10.5.4.3. Product benchmarking
      • 10.5.4.4. Strategic initiatives
    • 10.5.5. Primus Pharmaceuticals, Inc.
      • 10.5.5.1. Company overview
      • 10.5.5.2. Financial performance
      • 10.5.5.3. Product benchmarking
      • 10.5.5.4. Strategic initiatives
    • 10.5.6. Fresenius Kabi AG
      • 10.5.6.1. Company overview
      • 10.5.6.2. Financial performance
      • 10.5.6.3. Product benchmarking
      • 10.5.6.4. Strategic initiatives
    • 10.5.7. Mead Johnson & Company, LLC
      • 10.5.7.1. Company overview
      • 10.5.7.2. Financial performance
      • 10.5.7.3. Product benchmarking
      • 10.5.7.4. Strategic initiatives
  • 10.6. List of other market players
Show more
Product Code: GVR-4-68039-943-6

List of Tables

  • Table 1 List of abbreviations
  • Table 2 List of Secondary Sources
  • Table 3 Europe medical foods market, by region, 2021 - 2033 (USD Billion)
  • Table 4 Europe medical foods market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 5 Europe medical foods market, by product, 2021 - 2033 (USD Billion)
  • Table 6 Europe medical foods market, by application, 2021 - 2033 (USD Billion)
  • Table 7 Europe medical foods market, by modules, 2021 - 2033 (USD Billion)
  • Table 8 Europe medical foods market, by sales channel, 2021 - 2033 (USD Billion)
  • Table 9 Germany medical foods market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 10 Germany medical foods market, by product, 2021 - 2033 (USD Billion)
  • Table 11 Germany medical foods market, by application, 2021 - 2033 (USD Billion)
  • Table 12 Germany medical foods market, by modules, 2021 - 2033 (USD Billion)
  • Table 13 Germany medical foods market, by sales channel, 2021 - 2033 (USD Billion)
  • Table 14 UK medical foods market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 15 UK medical foods market, by product, 2021 - 2033 (USD Billion)
  • Table 16 UK medical foods market, by application, 2021 - 2033 (USD Billion)
  • Table 17 UK medical foods market, by modules, 2021 - 2033 (USD Billion)
  • Table 18 UK medical foods market, by sales channel, 2021 - 2033 (USD Billion)
  • Table 19 France medical foods market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 20 France medical foods market, by product, 2021 - 2033 (USD Billion)
  • Table 21 France medical foods market, by application, 2021 - 2033 (USD Billion)
  • Table 22 France medical foods market, by modules, 2021 - 2033 (USD Billion)
  • Table 23 France medical foods market, by sales channel, 2021 - 2033 (USD Billion)
  • Table 24 Italy medical foods market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 25 Italy medical foods market, by product, 2021 - 2033 (USD Billion)
  • Table 26 Italy medical foods market, by application, 2021 - 2033 (USD Billion)
  • Table 27 Italy medical foods market, by modules, 2021 - 2033 (USD Billion)
  • Table 28 Italy medical foods market, by sales channel, 2021 - 2033 (USD Billion)
  • Table 29 Spain medical foods market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 30 Spain medical foods market, by product, 2021 - 2033 (USD Billion)
  • Table 31 Spain medical foods market, by application, 2021 - 2033 (USD Billion)
  • Table 32 Spain medical foods market, by modules, 2021 - 2033 (USD Billion)
  • Table 33 Spain medical foods market, by sales channel, 2021 - 2033 (USD Billion)
  • Table 34 Denmark medical foods market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 35 Denmark medical foods market, by product, 2021 - 2033 (USD Billion)
  • Table 36 Denmark medical foods market, by application, 2021 - 2033 (USD Billion)
  • Table 37 Denmark medical foods market, by modules, 2021 - 2033 (USD Billion)
  • Table 38 Denmark medical foods market, by sales channel, 2021 - 2033 (USD Billion)
  • Table 39 Sweden medical foods market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 40 Sweden medical foods market, by product, 2021 - 2033 (USD Billion)
  • Table 41 Sweden medical foods market, by application, 2021 - 2033 (USD Billion)
  • Table 42 Sweden medical foods market, by modules, 2021 - 2033 (USD Billion)
  • Table 43 Sweden medical foods market, by sales channel, 2021 - 2033 (USD Billion)
  • Table 44 Norway medical foods market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 45 Norway medical foods market, by product, 2021 - 2033 (USD Billion)
  • Table 46 Norway medical foods market, by application, 2021 - 2033 (USD Billion)
  • Table 47 Norway medical foods market, by modules, 2021 - 2033 (USD Billion)
  • Table 48 Norway medical foods market, by sales channel, 2021 - 2033 (USD Billion)
  • Table 49 Poland medical foods market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 50 Poland medical foods market, by product, 2021 - 2033 (USD Billion)
  • Table 51 Poland medical foods market, by application, 2021 - 2033 (USD Billion)
  • Table 52 Poland medical foods market, by modules, 2021 - 2033 (USD Billion)
  • Table 53 Poland medical foods market, by sales channel, 2021 - 2033 (USD Billion)
  • Table 54 Netherlands medical foods market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 55 Netherlands medical foods market, by product, 2021 - 2033 (USD Billion)
  • Table 56 Netherlands medical foods market, by application, 2021 - 2033 (USD Billion)
  • Table 57 Netherlands medical foods market, by modules, 2021 - 2033 (USD Billion)
  • Table 58 Netherlands medical foods market, by sales channel, 2021 - 2033 (USD Billion)
  • Table 59 Portugal medical foods market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 60 Portugal medical foods market, by product, 2021 - 2033 (USD Billion)
  • Table 61 Portugal medical foods market, by application, 2021 - 2033 (USD Billion)
  • Table 62 Portugal medical foods market, by modules, 2021 - 2033 (USD Billion)
  • Table 63 Portugal medical foods market, by sales channel, 2021 - 2033 (USD Billion)
  • Table 64 Slovakia medical foods market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 65 Slovakia medical foods market, by product, 2021 - 2033 (USD Billion)
  • Table 66 Slovakia medical foods market, by application, 2021 - 2033 (USD Billion)
  • Table 67 Slovakia medical foods market, by modules, 2021 - 2033 (USD Billion)
  • Table 68 Slovakia medical foods market, by sales channel, 2021 - 2033 (USD Billion)
  • Table 69 Finland medical foods market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 70 Finland medical foods market, by product, 2021 - 2033 (USD Billion)
  • Table 71 Finland medical foods market, by application, 2021 - 2033 (USD Billion)
  • Table 72 Finland medical foods market, by modules, 2021 - 2033 (USD Billion)
  • Table 73 Finland medical foods market, by sales channel, 2021 - 2033 (USD Billion)
  • Table 74 Czech Republic medical foods market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 75 Czech Republic medical foods market, by product, 2021 - 2033 (USD Billion)
  • Table 76 Czech Republic medical foods market, by application, 2021 - 2033 (USD Billion)
  • Table 77 Czech Republic medical foods market, by modules, 2021 - 2033 (USD Billion)
  • Table 78 Czech Republic medical foods market, by sales channel, 2021 - 2033 (USD Billion)
  • Table 79 Hungary medical foods market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 80 Hungary medical foods market, by product, 2021 - 2033 (USD Billion)
  • Table 81 Hungary medical foods market, by application, 2021 - 2033 (USD Billion)
  • Table 82 Hungary medical foods market, by modules, 2021 - 2033 (USD Billion)
  • Table 83 Hungary medical foods market, by sales channel, 2021 - 2033 (USD Billion)
  • Table 84 Belgium medical foods market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 85 Belgium medical foods market, by product, 2021 - 2033 (USD Billion)
  • Table 86 Belgium medical foods market, by application, 2021 - 2033 (USD Billion)
  • Table 87 Belgium medical foods market, by modules, 2021 - 2033 (USD Billion)
  • Table 88 Belgium medical foods market, by sales channel, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Europe medical foods market: market outlook
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Europe medical foods market driver impact
  • Fig. 14 Europe medical foods market restraint impact
  • Fig. 15 Europe medical foods market strategic initiatives analysis
  • Fig. 16 Europe medical foods market: Route of administration movement analysis
  • Fig. 17 Europe medical foods market: Route of administration outlook and key takeaways
  • Fig. 18 Oral market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 19 Enteral market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 20 Europe medical foods market: Product movement analysis
  • Fig. 21 Europe medical foods market: Product outlook and key takeaways
  • Fig. 22 Pills market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 23 Powder market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 24 Liquid market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 25 Others (semisolid, semiliquid) market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 26 Europe medical foods market: Application model analysis
  • Fig. 27 Europe medical foods market: Application model outlook and key takeaways
  • Fig. 28 Chronic kidney disease market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 29 Minimal hepatic encephalopathy market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 30 Chemotherapy induced diarrhea market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 31 Pathogen related infections market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 32 Diabetic neuropathy market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 33 ADHD market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 34 Depression market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 35 Alzheimer's disease market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 36 Nutritional deficiency market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 37 Orphan diseases market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 38 Tyrosinemia market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 39 Eosinophilic Esophagitis market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 40 Food Protein Module-induced enterocolitis syndrome (FPIES) market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 41 Phenylketonuria (PKU) market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 42 Maple syrup urine disease (MSUD) market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 43 Homocystinuria market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 44 Others (Urea Cycle Disorder (UCD), Glycogen Storage Disease (GSD), etc.) market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 45 Wound healing market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 46 Chronic diarrhea market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 47 Constipation relief market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 48 Protein booster market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 49 Dysphagia market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 50 Pain management market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 51 Parkinson's disease market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 52 Epilepsy market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 53 Other cancer related treatments market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 54 Severe protein allergy market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 55 Cancer market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 56 Chacexia market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 57 Other (debilitating conditions, COPD, etc.) market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 58 Europe medical foods market: Modules model analysis
  • Fig. 59 Europe medical foods market: Modules model outlook and key takeaways
  • Fig. 60 Amino acid module market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 61 Protein module market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 62 Vitamin & mineral modules market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 63 Fatty acid based modules market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 64 Carbohydrate modules market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 65 Fiber modules market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 66 Ketogenic modules market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 67 Peptide based modules market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 68 Hypoallergic modules market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 69 Others (electrolyte module, etc.) market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 70 Europe medical foods market: Sales channel model analysis
  • Fig. 71 Europe medical foods market: Sales channel model outlook and key takeaways
  • Fig. 72 DTC sales channel market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 73 Online sales market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 74 Retail sales market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 75 Institutional sales market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 76 Hospitals market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 77 Others (long-term care facilities, etc.) market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 78 Europe medical foods market: Country movement analysis
  • Fig. 79 Europe medical foods market: Country outlook and key takeaways
  • Fig. 80 Europe market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 81 UK
  • Fig. 82 UK market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 83 Germany
  • Fig. 84 Germany market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 85 France
  • Fig. 86 France market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 87 Italy
  • Fig. 88 Italy market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 89 Spain
  • Fig. 90 Spain market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 91 Denmark
  • Fig. 92 Denmark market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 93 Sweden
  • Fig. 94 Sweden market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 95 Norway
  • Fig. 96 Norway market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 97 Poland
  • Fig. 98 Poland market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 99 Netherlands
  • Fig. 100 Netherlands market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 101 Portugal
  • Fig. 102 Portugal market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 103 Slovakia
  • Fig. 104 Slovakia market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 105 Finland
  • Fig. 106 Finland market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 107 Czech Republic
  • Fig. 108 Czech Republic market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 109 Hungary
  • Fig. 110 Hungary market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 111 Belgium
  • Fig. 112 Belgium market estimates and forecasts, 2021 - 2033 (USD Billion)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!